---
title: "Damania Pharma Ltd (524398) — Share Price, Financials & Analysis"
symbol: "524398"
company: "Damania Pharma Ltd"
canonical: "https://tapetide.com/stocks/524398"
bse_code: "524398"
generated_at: "2026-10-13T10:59:43.095Z"
---

# Damania Pharma Ltd (524398)

Canonical page: https://tapetide.com/stocks/524398

## Company

- **BSE Code:** 524398
- **Stock Type:** EQUITY
- **Face Value:** ₹10
- **F&O Eligible:** No

## Latest Price

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 46 | 104 | 49 | 48 | 51 | 54 | 67 | 74 | 54 |
| Expenses | 37 | 69 | 32 | 33 | 33 | 38 | 45 | 51 | 36 |
| Operating Profit | 9 | 35 | 18 | 15 | 18 | 17 | 22 | 24 | 17 |
| OPM % | 19 | 34 | 36 | 31 | 36 | 30 | 33 | 32 | 33 |
| Other Income | 0 | 3 | 1 | 0 | 1 | 3 | 3 | 3 | 2 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | 9 | 37 | 18 | 15 | 19 | 19 | 25 | 26 | 19 |
| Tax % | 25 | 27 | 27 | 27 | 22 | 29 | 25 | 26 | 26 |
| Net Profit | 7 | 27 | 13 | 11 | 15 | 14 | 19 | 19 | 14 |
| EPS in Rs | 3.45 | 14.22 | 6.85 | 5.76 | 7.79 | 5.14 | 6.95 | 7.09 | 5.34 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 |
| --- | --- | --- | --- | --- | --- |
| Sales | 0 | 0 | 0 | 0 | 0 |
| Expenses | 0 | 0 | 0 | 0 | 0 |
| Operating Profit | 0 | 0 | 0 | 0 | 0 |
| Other Income | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 0 | 0 | 0 | 0 | 0 |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 |
| --- | --- | --- | --- | --- | --- |
| Equity Capital | 0.03 | 0.03 | 3 | 3 | 3 |
| Reserves | -0.03 | -0.03 | -3 | -3 | -3 |
| Borrowings | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 0 | 0 | 0 | 0 | 0 |
| Fixed Assets | 0 | 0 | 0 | 0 | 0 |
| CWIP | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 0 | 0 | 0 | 0 | 0 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
| --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 1 | 26 | -8 | 52 | 27 | -72 |
| Cash from Investing Activity | 0 | 0 | -4 | -30 | 0 | 18 |
| Cash from Financing Activity | 0 | 0 | 0 | 1 | -1 | 191 |
| Net Cash Flow | 0 | 25 | -12 | 23 | 26 | 137 |

### Ratios

| Item | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
| --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 24 | 46 | 41 | 48 | 39 | 154 |
| Inventory Days | — | — | — | 23 | 115 | 1306 |
| Days Payable | — | — | — | 34 | 66 | 246 |
| Cash Conversion Cycle | 24 | 46 | 41 | 37 | 88 | 1214 |
| Working Capital Days | -83 | -196 | 93 | 49 | 87 | 322 |
| ROCE % | — | 122 | 147 | 85 | 60 | 25 |

## Shareholding Pattern

### annual

| Category | Mar 2025 | Dec 2025 |
| --- | --- | --- |
| Promoters | 71.91% | 71.91% |
| FIIs | 1.88% | 0% |
| DIIs | 5.12% | 0.63% |
| Public | 21.08% | 27.46% |
| No. of Shareholders | 38311 | 40566 |

### Quarterly

| Category | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
| --- | --- | --- | --- | --- |
| Promoters | 71.91% | 71.91% | 71.91% | 71.91% |
| FIIs | 1.88% | 1.11% | 0.25% | 0% |
| DIIs | 5.12% | 2.86% | 1.9% | 0.63% |
| Public | 21.08% | 24.1% | 25.94% | 27.46% |
| No. of Shareholders | 38311 | 39787 | 39462 | 40566 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Sell
- **Buy / Neutral / Sell:** 5 / 2 / 12

### Moving Averages — summary: **Strong Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 145.09 | Sell |
| EMA (10) | 144.87 | Sell |
| SMA (20) | 155.19 | Sell |
| EMA (20) | 152.51 | Sell |
| SMA (50) | 172.81 | Sell |
| EMA (50) | 169.26 | Sell |
| SMA (100) | 194.46 | Sell |
| EMA (100) | 187.97 | Sell |
| SMA (200) | 216.45 | Sell |
| EMA (200) | 218.56 | Sell |

### Oscillators — summary: **Strong Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 26.84 | Buy |
| MACD (12,26,9) | -9.77 | Sell |
| Stochastic (14,3,3) | 9.88 | Buy |
| ADX (14) | 41.23 | Buy |
| Williams %R (14) | -90.59 | Buy |
| ATR (14) | 6.38 | High Volatility |
| ROC (12) | -14.71 | Sell |
| Stoch RSI (14) | 31.62 | Neutral |
| UO (7,14,28) | 29.08 | Buy |

## Filings & Documents

### Other Documents

| Date | Document |
| --- | --- |
| 2026-03-02 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation](https://www.bseindia.com/xml-data/corpfiling/AttachHis/ab6e37a9-89c9-4743-9d59-90859d55b99b.pdf) |
| 2026-02-20 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/xml-data/corpfiling/AttachHis/c9fd5f1c-c393-463a-81ff-4e8bf6b84159.pdf) |
| 2026-02-19 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/xml-data/corpfiling/AttachHis/89fa5d17-b432-45f2-b409-6d92e1182bca.pdf) |
| 2026-02-19 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/xml-data/corpfiling/AttachHis/767f909d-5c23-4914-ae29-3a5e5175201c.pdf) |
| 2026-02-14 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/xml-data/corpfiling/AttachHis/93101a00-2595-4a0d-8084-2588e9050139.pdf) |
| 2026-02-13 | [Announcement under Regulation 30 (LODR)-Press Release / Media Release](https://www.bseindia.com/xml-data/corpfiling/AttachHis/7635081b-288b-43cd-a709-fc66d277e8f2.pdf) |
| 2026-02-13 | [Review Of Operations And Business Update](https://www.bseindia.com/xml-data/corpfiling/AttachLive/45b1b24c-9b9d-4759-80de-974441bcfb4f.pdf) |
| 2026-02-13 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation](https://www.bseindia.com/xml-data/corpfiling/AttachLive/7cd565ab-9182-48d2-8c70-f9439842973c.pdf) |
| 2026-02-12 | [General Update](https://www.bseindia.com/xml-data/corpfiling/AttachLive/a1115996-c456-4ade-86bc-9d77ffa82933.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| 2025 | [Financial Year 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/b3fe50a6-f201-43b2-b207-0e807dcb7636.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Feb 2026 | [Concall - Feb 2026](https://www.bseindia.com/xml-data/corpfiling/AttachHis/c9fd5f1c-c393-463a-81ff-4e8bf6b84159.pdf) |
| Nov 2025 | [Concall - Nov 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/17fdff92-51ac-42c7-95f2-8f65308a617f.pdf) |
| Aug 2025 | [Concall - Aug 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/a8f5d397-8d69-47fe-a2cd-6b8d28575161.pdf) |
| Jun 2025 | [Concall - Jun 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/865d3ff1-f506-41dc-98a0-d7050089189c.pdf) |

### Credit Rating Reports

| Date | Document |
| --- | --- |
| 2025-04-04 | Credit rating update — CARE Ratings |
| 2024-04-02 | Credit rating update — CARE Ratings |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-10-13T10:59:43.095Z.